MODD vs. PDEX, LNSR, RCEL, LAKE, INFU, AVR, PTHL, LUCD, LUNG, and OBIO
Should you be buying Modular Medical stock or one of its competitors? The main competitors of Modular Medical include Pro-Dex (PDEX), LENSAR (LNSR), Avita Medical (RCEL), Lakeland Industries (LAKE), InfuSystem (INFU), Anteris Technologies Global (AVR), Pheton (PTHL), Lucid Diagnostics (LUCD), Pulmonx (LUNG), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.
Modular Medical vs. Its Competitors
Modular Medical (NASDAQ:MODD) and Pro-Dex (NASDAQ:PDEX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.
27.5% of Modular Medical shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 20.5% of Modular Medical shares are owned by company insiders. Comparatively, 47.5% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Pro-Dex has a consensus target price of $56.00, indicating a potential upside of 17.82%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts plainly believe Pro-Dex is more favorable than Modular Medical.
Pro-Dex has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.
In the previous week, Pro-Dex had 1 more articles in the media than Modular Medical. MarketBeat recorded 2 mentions for Pro-Dex and 1 mentions for Modular Medical. Modular Medical's average media sentiment score of 1.89 beat Pro-Dex's score of 0.94 indicating that Modular Medical is being referred to more favorably in the media.
Pro-Dex has a net margin of 14.61% compared to Modular Medical's net margin of 0.00%. Pro-Dex's return on equity of 29.08% beat Modular Medical's return on equity.
Modular Medical has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Comparatively, Pro-Dex has a beta of 0.19, suggesting that its stock price is 81% less volatile than the S&P 500.
Summary
Pro-Dex beats Modular Medical on 13 of the 15 factors compared between the two stocks.
Get Modular Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MODD and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Modular Medical Competitors List
Related Companies and Tools
This page (NASDAQ:MODD) was last updated on 7/17/2025 by MarketBeat.com Staff
Free MODD Stock Alerts